From Genotype to Prescription: How Germline Pharmacogenetics Is Reshaping Drug Safety
Genetics severely impacts on the response to some drugs and adverse drug reactions (ADRs) remain a major and largely preventable burden for healthcare systems. In Europe, ADRs account for approximately 5% of hospital admissions, while in the United States they contribute to over one million emergency department visits annually. Germline pharmacogenetic (PGx) testing are actually […]